Nanobiotix Expands US Leadership Team
Nanobiotix has made two new appointments – one related to clinical development and the other to investor relations – to its US team.
You may also be interested in...
Nanobiotix gains more clinical evidence to support its nanoparticle technology in combination with radiotherapy to enhance treatment outcomes in cancer patients.
The European Court of Justice has confirmed the European Medicines Agency’s approach to disclosure of data submitted as part of a marketing authorization application. It is a big disappointment for industry, which nonetheless says it supports responsible data sharing and will support efforts to develop a balanced approach.